KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Accounts Payables (2018 - 2024)

BioNTech SE's Accounts Payables history spans 7 years, with the latest figure at $456.0 million for Q4 2024.

  • For Q4 2024, Accounts Payables rose 19.71% year-over-year to $456.0 million; the TTM value through Dec 2024 reached $456.0 million, up 19.71%, while the annual FY2024 figure was $461.8 million, 20.61% up from the prior year.
  • Accounts Payables for Q4 2024 was $456.0 million at BioNTech SE, up from $380.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $456.0 million in Q4 2024 and bottomed at $122.0 million in Q4 2020.
  • The 5-year median for Accounts Payables is $208.2 million (2022), against an average of $270.0 million.
  • The largest annual shift saw Accounts Payables skyrocketed 437.58% in 2020 before it increased 13.77% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $122.0 million in 2020, then surged by 50.06% to $183.0 million in 2021, then rose by 13.77% to $208.2 million in 2022, then soared by 82.91% to $380.9 million in 2023, then increased by 19.71% to $456.0 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Accounts Payables are $456.0 million (Q4 2024), $380.9 million (Q4 2023), and $208.2 million (Q4 2022).